Pituitary hormones folitropin (follicle-stimulating hormone, FSH) and lutropin (luteinising hormone, LH) are known as the key regulators of human reproduction. However, their receptors have been identified also in several organs and tissues beyond the reproductive system, and there is cumulating evidence of their direct extra-gonadal actions. The expression of LH receptors (LHR) was found in the brain and adrenal cortex. FSH receptors (FSHR) were found to be expressed in osteoclasts, monocytes, adipocytes, and peri-and intra-tumoural blood vessel endothelia of malignant tumours. Other localisations of FSHR and LHR are also suggested by immunohistochemistry, but these findings need confirmation using molecular biology techniques. Because the high levels of gonadotropins are a constant phenomenon during human aging, especially in postmenopausal women, it is hypothesised that the direct actions of FSH and LH are involved in the pathogenesis of age-related disorders. The proposal of therapy based on the inhibition of gonadotropin hypersecretion is also discussed. (Endokrynol Pol 2019; 70 (5): 438-441)
Introduction
Glycoprotein hormones: folitropin (follicle-stimulating hormone, FSH) and lutropin (luteinising hormone, LH) are known as key regulators of the mammalian reproductive system. Their numerous effects beyond the reproductive system are considered as indirect, exerted via ovarian and testicular steroid hormones. Nevertheless, the first data indicating the possible direct (i.e. independent of gonadal steroids) actions of gonadotropins were published in the 1960s [1] [2] [3] [4] . The quoted authors described the morphological effects of FSH and/or LH administration in the adrenal cortex [2] [3] [4] and in autonomic ganglia of hypophysectomised-gonadectomised rats [1] . In 1994 the authors of this review proposed a hypothesis that gonadotropin excess via their direct actions is involved in human aging [5] . Nowadays numerous additional data indicating the possibility of the direct action of gonadotropins as well as the occurrence of their receptors beyond the reproductive system are reported. However, the meaning of direct gonadotropin actions is still undervalued. The present review discusses the data on the extra-gonadal actions of gonadotropins on the adrenal gland, bone, fat tissue, and immune and nervous systems and their role in neoplasia and aging.
Adrenal cortex
As was indicated in the introduction, the direct effects of both gonadotropins were shown in the 1960s on the model of hypophysectomised-gonadectomised rats [2] [3] [4] . More recently the presence of LH/CG receptors mRNA and protein has been revealed in the zona reticularis and deeper zona fasciculata of the human adrenal gland [6] . The presence of LH/CGR was also shown by immunohistochemistry in all zones of the rhesus ape [7] and human adrenal cortex [8] . Further studies not only confirmed the expression of LH/CG receptor in normal human adrenal cortex but also reported their increased expression in nodular adrenal hyperplasia or adrenal adenomas connected with Cushing's syndrome [9] [10] [11] and in aldosterone-producing adenomas [12] [13] [14] , as well as in adrenocortical cancers [15] . The functionality of adrenocortical LH/CG receptors was documented by in vitro effects of chorionic gonadotropin on cortisol [10] and aldosterone [12] secretion. LH and chorionic gonadotropin are also involved in adrenocortical hyperfunction [16] Moreover, the involvement of LH in adrenocortical tumourigenesis was demonstrated in transgenic mice [17, 18] . Although the early studies concerned not only LH, but also FSH [2] [3] [4] , more recent investigations on this topic are almost absent. [33] . Higher LH levels are also associated with poor memory recall in men, independently of testosterone concentrations [34] . LH levels are also higher in patients suffering from AD than in non-AD subjects. The high levels of LH are considered as a risk factor of AD [35] . The mechanism of the neurodegenerative action of LH seems to depend on LH/CG receptors in the brain (see above). In animal studies, LH was found to increase the accumulation of AD-specific protein b-amyloid [36] . The down-regulation of gonadotropins by means of GnRH analogues leads to improvement in the animal model of AD [37] [38] [39] . These results are the basis of the first clinical trials on the treatment of AD with GnRH analogue leuprolide acetate [40] .
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Bone
FSH receptors were revealed in osteoclasts [41] and in chondrocytes [42] . Several data indicate that FSH oversecretion, independently of gonadal deficiency, is responsible for bone loss [43] .
Fat tissue
As early as in the 1960s Romer [44] found that the morphological alterations in the brown fat tissue of the rat induced by hypophysectomy combined with gonadectomy might be reversed by the administration of chorionic gonadotropin. More recently, Liu et al. [45] demonstrated the presence of FSH receptors in mice and human adipocytes. The quoted authors assume that these receptors are involved in lipogenesis and hypothesise that aging-related obesity depends on the high FSH levels in elderly people. They described also the positive correlation of FSH and body mass index (BMI) in postmenopausal women. Recently, we have found the negative correlations of both FSH and LH with BMI in old women [46] , but our patients were much older (> 75 years) than those investigated by Liu et al. (51-55 years) . It cannot be excluded that in more advanced age the function of gonadotropin receptors is shifted towards lipolysis. Independently of the precise mechanisms at the molecular level, both observations could be interpreted as the direct action of gonadotropins on the fat tissue, because the mediation of ovaries is unlikely in postmenopausal women.
Immune system
FSHR were identified in human monocytes [41] . Moreover, FSH, LH, and hCG were shown to enhance several cytokines from the human peripheral blood mononuclear cells in vitro. The above concerns interferon-gamma [47] , interleukin-6 [48] , interleukin Pawlikowski et al. [19] revealed immunopositivity with anti-FSHR antibody in human non-neoplastic adrenal cortex as well as in benign and malignant adrenal tumours; however, the specificity of this immunoreaction is still under discussion [20] 
Nervous system
One of the earliest findings of the direct action of gonadotropins on the nervous system was the observation of degenerative changes in autonomic gangliocytes after FSH or LH administration in hypophysectomised-gonadectomised rats [1] . Further evidence of the direct gonadotropin action of either LH or FSH on neurons was the discovery of "short" feedback loops in the control of gonadotropin secretion. Namely, it was demonstrated that the implantation of LH [21] or FSH [22] to median eminence leads to the decrease of the secretion of respective hormone, probably via suppression of Gn-RH-producing hypothalamic neurons. It has also been shown that LH modulates the activity of hippocampal function in rats [23] . More recently it was shown that LH/CG receptors and GnRH coexist in the same neurons of the rat preoptic area, and hCG is able to down-regulate the GnRH gene in immortalised hypothalamic neurons GT 1-7 in vitro [24] . The expression of LH/CG receptors was also found in numerous other structures of the rat brain [25] . The LH/CG receptors were also found in the peripheral and central nervous system during the foetal period, and their role in neuronal development (possibly mediated by neurosteroids) was hypothesised [26, 27] . LH itself was also found in the rodent brain by means of different techniques, including radioimmunoassay [28] and immunohistochemistry [29] ; it is present in the hypothalamus but also widely distributed in different extrahypothalamic areas. By means of immunohistochemistry it was localised in neuronal cell bodies as well as in nerve fibres [29] . The inverse relationship between peripheral LH and brain LH exerted via short feedback loop is also hypothesised [30] . The finding of LH/CR receptors and LH in the nervous system is fundamental to the explanation of the involvement of enhanced LH secretion in brain aging (see below).
The role of gonadotropins in brain aging and Alzheimer's disease
Alzheimer's disease (AD) is linked with aging and is prevalent in the female sex. Recent studies indicate that gonadotropins -mainly LH -play a pivotal role in the pathogenesis of AD [30] [31] [32] . The impairment of cognitive function scores is also observed in non-demented old women in dependence on high LH levels Gonadotropins -role in aging and neoplasia
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1b, and tumour necrosis factor-a [49] . It is obvious that gonadotropins, especially their high levels occurring in menopausal and postmenopausal women, may modulate the immune system function.
The role of gonadotropins in neoplasia
In 2010 Radu et al. [50] reported an important observation concerning peri-and intratumoural vasculature in malignant tumours. The quoted authors found that the endothelia of peritumoral and intratumoural blood vessels in malignant neoplasms express FSHR. In contrast, the non-tumoural blood vessels (with the exception of the vasculature in the reproductive organs and umbilical veins) do not contain FSHR protein. This observation was confirmed soon after by other authors [19, [51] [52] [53] .
It seems reasonable to suppose that FSHR-positive blood vessels represent the vasculature formed through tumoral neo-angiogenesis, and like in their classical targets, i.e. the reproductive organs, are involved in the neo-angiogenesis process [54] . FSHR were also demonstrated by means of immunohistochemistry in tumoural cells, mostly in tumours of endocrine origin [19, [51] [52] [53] 55] . However, in contrast to the expression of FSHR in tumoural cells of the gonadal [18, 56] and prostatic tumours [57, 58] , which is well established, their occurrence in tumoural cells beyond the reproductive system is still controversial. The presence of FSHR (at least at the vascular level) in malignant tumours allowed the proposal of novel therapies based on FSHR antagonists, FSHR radioactive ligands, or FSH secretion inhibitors [for review see: [59] [60] [61] . It seems that the role of LH in neoplasia beyond the reproductive system is more limited. The LH/CGR are expressed in human adrenocortical adenomas and cancers, and the involvement of LH in adrenal tumorigenesis was shown in mice (see paragraph Adrenal cortex). LH/CGR was also shown in breast cancer, and its expression is increased in invasive vs. preinvasive tumours [62] .
Conclusions and perspectives
The data presented above indicate that in different organs and tissues beyond the reproductive system expression of gonadotropin receptors occurs. These receptors may mediate the direct effects of the hormones in question. It concerns mainly older people, when gonadotropin secretion is persistently enhanced. It can be concluded that the age-related alterations of the vital functions depend not only on the deficiency of some hormones (mostly the gonadal steroids) but also on gonadotropin excess. The inhibition of gonadotropin excess (e.g. by means of GnRH antagonists) may be a promising alternative to gonadal hormone replacement therapies. It can be expected that the inhibition of gonadotropin hypersecretion will result in the improvement of mental status and prevent osteoporosis and cancer. Obviously, these presumptions need confirmation in further studies.
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Bezpośrednie działanie gonadotropin poza układem rozrodczym i ich rola w starzeniu się i nowotworzeniu u człowieka
Marek Pawlikowski 
Wprowadzenie
Hormony glikoproteinowe folitropina (FSH, follicle stimulating hormone) i lutropina (LH, luteinizing hormone) znane są jako kluczowe regulatory układu rozrodczego ssaków. Większość ich działań poza układem rozrodczym uważa się za niemające bezpośredniego charakteru, lecz zachodzące za pośrednictwem steroidowych hormonów wytwarzanych przez jajnik i jądro. Pierwsze dane wskazujące jednak na bezpośrednie (tj. niezależne od steroidów gonadowych) działania gonadotropin opublikowano już w latach 60. XX w. [1] [2] [3] [4] . Cytowani autorzy opisali morfologiczne efekty podawania FSH i/lub LH na korę nadnerczy [2] [3] [4] i zwoje nerwowe układu autonomicznego [1] u szczurów poddanych równoczesnej hipofizektomii i gonadektomii. W 1994 r. autor niniejszej pracy zaproponował hipotezę, w myśl której nadmiar gonadotropin poprzez swoje bezpośrednie działanie, uczestniczy w procesie starzenia się u ludzi [5] . Obecnie liczne dodatkowe doniesienia potwierdzają możliwość bezpośredniego działania gonadotropin, jak również wskazują na obecność ich receptorów poza układem rozrodczym. Nadal jednak znaczenie bezpośredniego pozagonadowego działania gonadotropin jest niedoceniane. W tej pracy poglądowej omówiono dane dotyczące pozagonadowego działania gonadotropin na korę nadnerczy, układ kostny, układ immunologiczny i nerwowy oraz rolę tych działań w procesach nowotworzenia i starzenia się.
Kora nadnerczy
Jak już wspomniano we wprowadzeniu, bezpośrednie efekty obu gonadotropin wykazano już w latach 60. ubiegłego stulecia na modelu szczurów poddanych równoczesnej hipofizektomii i gonadektomii [2] [3] [4] . W późniejszych latach wykazano obecność mRNA dla receptora lutropiny i gonadotropiny kosmówko- 
